Published in Lung on April 11, 2010
Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med (2012) 2.44
Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med (2014) 1.51
Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis (2013) 1.31
The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. Pharmacoepidemiol Drug Saf (2010) 1.11
Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns. Lung (2011) 0.94
Highlight on advances in nontuberculous mycobacterial disease in North America. Biomed Res Int (2014) 0.94
Opinions differ by expertise in Mycobacterium avium complex disease. Ann Am Thorac Soc (2014) 0.79
Gender susceptibility to mycobacterial infections in patients with non-CF bronchiectasis. Int J Mycobacteriol (2015) 0.77
Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013. Emerg Infect Dis (2017) 0.75
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med (2007) 33.18
Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med (1989) 5.79
Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med (2008) 4.33
Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med (2002) 4.14
Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol (1999) 4.10
Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest (2006) 3.66
The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis (1987) 3.48
Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax (2007) 3.36
Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis (2009) 3.09
Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. Int J Syst Evol Microbiol (2004) 2.62
Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin Microbiol Rev (2001) 2.36
Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax (2009) 1.91
Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med (2007) 1.82
Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest (1999) 1.80
Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. Chest (1992) 1.75
A demographic study of disease due to Mycobacterium kansasii or M intracellulare-avium in Texas. Chest (1979) 1.73
Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg Infect Dis (2008) 1.69
Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J (2006) 1.57
Nontuberculous mycobacterial disease in northern Australia: a case series and review of the literature. Clin Infect Dis (2000) 1.55
Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am Rev Respir Dis (1988) 1.51
Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS. J Clin Microbiol (2005) 1.30
Endemic contamination of clinical specimens by Mycobacterium gordonae. Clin Infect Dis (2000) 1.27
Atypical mycobacteria. Their clinical, laboratory, and epidemiologic significance. Medicine (Baltimore) (1970) 1.26
Infection with the avian-Battey group of mycobacteria in England and Wales. Br Med J (1969) 1.19
Mycobacterium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting. Am Rev Respir Dis (1991) 1.15
Mycobacteria in a New England hospital. A study of mycobacterial species occurring in the sputum of patients with chronic pulmonary disease. Am Rev Respir Dis (1968) 1.14
The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong. Respir Med (1995) 1.09
Mycobacterium kansasii infection in an endemic area of Czechoslovakia. Tubercle (1980) 1.08
Clinical significance of nontuberculous mycobacteria isolates in a Canadian tertiary care center. Clin Infect Dis (1995) 1.08
Mycobacterium saskatchewanense sp. nov., a novel slowly growing scotochromogenic species from human clinical isolates related to Mycobacterium interjectum and Accuprobe-positive for Mycobacterium avium complex. Int J Syst Evol Microbiol (2004) 1.05
Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern Med (2008) 1.04
Atypical mycobacteria in a tuberculosis hospital. Can Med Assoc J (1976) 1.03
Increasing incidence of Mycobacterium xenopi at Bellevue hospital: An emerging pathogen or a product of improved laboratory methods? Chest (2000) 0.99
Incidence of nontuberculous mycobacterial disease in New Zealand, 2004. N Z Med J (2007) 0.98
Nontuberculous mycobacteria isolates: clinical significance and disease spectrum. J Formos Med Assoc (1997) 0.97
Atypical mycobacterial disease in British Columbia, 1960-1967. Can Med Assoc J (1969) 0.94
Disease due to Mycobacterium kansasii in the Czech Republic: 1984-89. Tuber Lung Dis (1995) 0.94
The epidemiology of opportunist mycobacterial infections in Wales, 1952--1978. Rev Infect Dis (1982) 0.91
Epidemiology and clinical significance of mycobacterial respiratory infections in Central Greece. Int J Tuberc Lung Dis (2008) 0.89
Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis (2008) 0.87
Nontuberculous mycobacterial disease. Experience in a southern California hospital. Arch Intern Med (1983) 0.86
Mycobacterium xenopi pulmonary disease - epidemiology and clinical features in non-immunocompromised patients. J Infect (2009) 0.83
Pulmonary Mycobacterium xenopi infection in non-HIV-infected patients: a systematic review. Int J Tuberc Lung Dis (2009) 0.82
A clinical comparison between Mycobacterium avium and Mycobacterium intracellulare infections. Chest (1993) 0.78
[Clinical and epidemiological study of disease caused by Mycobacterium kansasii in the metropolitan area of Bilbao, Spain]. Arch Bronconeumol (2005) 0.77
[Clinical features of the lung diseases due to Mycobacterium avium and M. intracellulare]. Kekkaku (1993) 0.75
Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax (2007) 3.36
Ceftiofur resistance in Salmonella enterica serovar Heidelberg from chicken meat and humans, Canada. Emerg Infect Dis (2010) 3.01
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J (2013) 2.80
Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol (2009) 1.75
Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype typhimurium infections. J Infect Dis (2004) 1.69
Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children. Pediatr Infect Dis J (2009) 1.67
Characterization of waterborne outbreak-associated Campylobacter jejuni, Walkerton, Ontario. Emerg Infect Dis (2003) 1.59
Utility of gastric aspirates for diagnosing tuberculosis in children in a low prevalence area: predictors of positive cultures and significance of non-tuberculous mycobacteria. Pediatr Infect Dis J (2015) 1.54
Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience. CMAJ (2004) 1.50
Use of the oxford multilocus sequence typing protocol and sequencing of the flagellin short variable region to characterize isolates from a large outbreak of waterborne Campylobacter sp. strains in Walkerton, Ontario, Canada. J Clin Microbiol (2005) 1.37
Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol (2004) 1.34
Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis (2013) 1.31
Blastomycosis in Ontario, 1994-2003. Emerg Infect Dis (2006) 1.30
VanG-type vancomycin-resistant Enterococcus faecalis strains isolated in Canada. Antimicrob Agents Chemother (2006) 1.26
Phenotypic and molecular characterization of clinical isolates of Mycobacterium elephantis from human specimens. J Clin Microbiol (2002) 1.23
Outbreak of serogroup C meningococcal disease caused by a variant of Neisseria meningitidis serotype 2a ET-15 in a community of men who have sex with men. J Clin Microbiol (2003) 1.16
Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario in 2007. Can Respir J (2011) 1.16
Prevalence of and risk factors for quinolone-resistant Neisseria gonorrhoeae infection in Ontario. CMAJ (2009) 1.14
Method for inactivating and fixing unstained smear preparations of mycobacterium tuberculosis for improved laboratory safety. J Clin Microbiol (2002) 1.14
Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates from Ontario, Canada. J Antimicrob Chemother (2009) 1.10
Are peripheral microscopy centres ready for next generation molecular tuberculosis diagnostics? Eur Respir J (2013) 1.10
Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors. Pediatr Pulmonol (2009) 1.09
Limited genetic diversity in Salmonella enterica serovar Enteritidis PT13. BMC Microbiol (2007) 1.08
Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135. Can J Microbiol (2008) 1.06
Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006. Antimicrob Agents Chemother (2010) 1.06
Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006. Vaccine (2009) 1.05
New endemic Legionella pneumophila serogroup I clones, Ontario, Canada. Emerg Infect Dis (2010) 1.05
Onychomycosis: a critical study of techniques and criteria for confirming the etiologic significance of nondermatophytes. Med Mycol (2005) 1.03
Rhinovirus outbreaks in long-term care facilities, Ontario, Canada. Emerg Infect Dis (2010) 1.02
Active tuberculosis among homeless persons, Toronto, Ontario, Canada, 1998-2007. Emerg Infect Dis (2011) 1.02
Leprosy-like illness in a patient with Mycobacterium lepromatosis from Ontario, Canada. J Drugs Dermatol (2012) 1.01
Molecular typing of a Legionella pneumophila outbreak in Ontario, Canada. J Med Microbiol (2007) 1.01
Going with the flow: legionellosis risk in Toronto, Canada is strongly associated with local watershed hydrology. Ecohealth (2009) 0.97
Severe human rhinovirus outbreak associated with fatalities in a long-term care facility in Ontario, Canada. J Am Geriatr Soc (2010) 0.96
Bordetella holmesii, an emerging cause of septic arthritis. J Clin Microbiol (2013) 0.93
Whole-genome sequence of Streptococcus pseudopneumoniae isolate IS7493. J Bacteriol (2011) 0.93
Multidrug and extensively drug-resistant tuberculosis in Canada 1997-2008: demographic and disease characteristics. PLoS One (2013) 0.93
Pertussis resurgence in Toronto, Canada: a population-based study including test-incidence feedback modeling. BMC Public Health (2011) 0.93
Mycobacterium lacus sp. nov., a novel slowly growing, non-chromogenic clinical isolate. Int J Syst Evol Microbiol (2002) 0.90
Laboratory-based evaluation of legionellosis epidemiology in Ontario, Canada, 1978 to 2006. BMC Infect Dis (2009) 0.89
Canadian multicenter laboratory study for standardized second-line antimicrobial susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2011) 0.88
Evidence for local transmission and reactivation of tuberculosis in the Toronto Somali community. Scand J Infect Dis (2006) 0.87
Outbreak of Escherichia coli 0157:H7 related to animal contact at a petting zoo. Can J Infect Dis (2002) 0.84
A descriptive study of human Salmonella serotype typhimurium infections reported in Ontario from 1990 to 1998. Can J Infect Dis (2003) 0.84
Hot tub lung mimicking classic acute and chronic hypersensitivity pneumonitis: two case reports. Can Respir J (2007) 0.84
Antimicrobial resistance among Salmonella and Shigella isolates in five Canadian provinces (1997 to 2000). Can J Infect Dis Med Microbiol (2006) 0.84
Respiratory virus infection and risk of invasive meningococcal disease in central Ontario, Canada. PLoS One (2010) 0.83
Mycobacterium tuberculosis in Ontario, Canada: Insights from IS6110 restriction fragment length polymorphism and mycobacterial interspersed repetitive-unit-variable-number tandem-repeat genotyping. J Clin Microbiol (2009) 0.83
Contamination of bone marrow products with an actinomycete resembling Microbacterium species and reinfusion into autologous stem cell and bone marrow transplant recipients. Clin Infect Dis (2003) 0.82
Nosocomial transmission of congenital tuberculosis in a neonatal intensive care unit. Clin Infect Dis (2004) 0.82
Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine. Can J Microbiol (2005) 0.82
Comparison of in-house and commercial 16S rRNA sequencing with high-performance liquid chromatography and genotype AS and CM for identification of nontuberculous mycobacteria. Diagn Microbiol Infect Dis (2008) 0.81
Increasing fluoroquinolone resistance in Salmonella typhi in Ontario, 2002-2007. Am J Trop Med Hyg (2009) 0.81
The Ontario universal typing of tuberculosis (OUT-TB) surveillance program--what it means to you. Can Respir J (2010) 0.81
Mass antibiotic treatment for group A streptococcus outbreaks in two long-term care facilities. Emerg Infect Dis (2003) 0.80
Multiattribute evaluation of two simple tests for the detection of Cryptosporidium parvum in calf faeces. Vet Parasitol (2005) 0.79
The relative test performance characteristics of two commercial assays for the detection of Mycobacterium tuberculosis complex in paraffin-fixed human biopsy specimens. Diagn Pathol (2008) 0.79
Decentralized molecular diagnostic testing plan for pandemic influenza in the Ontario Public Health Laboratory system. Can J Public Health (2008) 0.78
First Canadian Salmonella enterica serovar typhi isolate harboring an integron. Antimicrob Agents Chemother (2004) 0.77
Verification of the ProPneumo-1 assay for the simultaneous detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae in clinical respiratory specimens. Ann Clin Microbiol Antimicrob (2009) 0.77
Tuberculosis outbreak in a long-term care facility. Can J Public Health (2013) 0.77
Outbreak of acupuncture-associated cutaneous Mycobacterium abscessus infections. J Cutan Med Surg (2007) 0.76
False-positive amplified Mycobacterium tuberculosis direct test results for samples containing Mycobacterium leprae. J Clin Microbiol (2006) 0.75
Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: A decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009. Can J Infect Dis Med Microbiol (2012) 0.75
Transmission of influenza A pandemic (H1N1) 2009 virus in a long-term care facility in Ontario, Canada. Infect Control Hosp Epidemiol (2010) 0.75
Evaluation of a one-step biochemical screening test to determine pathogenic strains of Yersinia enterocolitica. Adv Exp Med Biol (2003) 0.75